Feds must maintain health care momentum in fall economic statement
Creating meaningful, long-lasting change in our health system will require sustained funding with clear, measurable, and transparent results.
Government hostility to biopharmaceutical industry reduces access to innovative drugs
Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need new drugs either have their access long delayed, or denied.
Canada’s opportunity to lead on sustainable menstrual equity
Ending period poverty in this generation is 100 per cent achievable.
The nurses and docs are not okay
The health-care system is still in a state of crisis, and we have starved health care in Canada so that COVID hit it like a wrecking ball.
It’s time for action in Canada’s fight against superbugs
Canada could transform from global laggard to a global leader in the fight against antimicrobial resistance.
Lead the charge: your community holds the key to revolutionizing mental health care
As the Liberal government continues to reset its priorities, the onus is clear: prioritize community mental health. It is a powerful solution in supporting the well-being of our most vulnerable citizens.
Parkinson’s has no cure, but the government can take steps to improve patients’ quality of life
Our nation has one of the highest rates of Parkinson’s in the world, with more than 100,000 Canadians living with the disease. Every day, 30 people in Canada are diagnosed, and that number will grow to 50 people per day in less than a decade.
Only single-payer universal pharmacare will save money, and lives, writes Canadian Health Coalition
The Hill Times’ Peter Mazereeuw’s take on the pharmacare costing analysis by the Office of the Parliamentary Budget Officer left me wondering whether we were reading the same study (The Hill Times, Oct. 13, 2023). Mazereeuw reports accurately that the PBO finds public universal pharmacare will deliver significant cost savings to the economy of $1.4-billion […]
Pharmacare means pharmaceuticals will be more affordable for everybody, writes Thomlinson
I was disappointed in the story about the PBO analysis of the cost of pharmacare and its focus on the question “what is its purpose?” Actually, the purpose is self-evident: to make pharmaceuticals more affordable for everybody. It is too clever by half to keep repeating the mantra that only 14 per cent of non-hospital […]
Liberals risk ‘intense criticism’ from Conservatives if pharmacare grows federal deficit, says pollster Bruce Anderson
Recent reports from the Parliamentary Budget Office found that a universal pharmacare program could cost both provincial and federal governments $11.2-billion in its first year, while the federal deficit is already projected to grow to $46.5-billion next year.
